New PowerTOST function(s) [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2015-09-22 16:59 (3927 d 00:19 ago) – Posting: # 15449
Views: 19,597

Dear Helmut,

❝ welcome back! How was vacation on the lonesome isle far out on the high seas?


Thanks! It was very recreative. And I could practise what I have to do if I will be a rendeer (German Rentier) next time.
Doing nothing the whole blessed day but "Maulaffen feil halten" (to gawk, to sit on one's hands) :cool:.

❝ I would not add other argument(s) to power.NTIDFDA(). AFAIK dabigatran is not a NTID.


That astonishes me. I had interpreted the sentence "Dabigatran demonstrated a steep exposure response relationship for both efficacy and safety." as some sort of NTID.

❝ Let’s ask Ben as well.


Good idea. I will wait for his reaction.

BTW: Do you think this sort of BE evaluation is not an "Eintagsfliege" (nine day wonder, ephemera), specific for dabigatran?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
125 visitors (0 registered, 125 guests [including 19 identified bots]).
Forum time: 17:19 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5